Not getting enough of deeper stages of sleep raises the risk of brain deterioration associated with Alzheimer’s disease, a ...
Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...
The explanation of Alzheimer's, given the span of the disease, could become more of an ongoing process for the child rather ...
Eli Lilly on Thursday expanded its direct-to-consumer online platform LillyDirect to include telehealth providers to diagnose ...
A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...
Eli Lilly & Co. is adding Alzheimer’s disease resources to the online platform it launched a year ago to sell obesity, ...
Researchers from Charité - Universitätsmedizin Berlin and the Max Delbrück Center have identified the precise mechanism by ...
New research shows that reduced time in slow wave and REM sleep is associated with smaller brain volumes in regions ...
Current Alzheimer’s therapies are most effective in early stages of the disease. The post New Alzheimer’s blood test can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback